ArticleIn vivo (Athens, Greece)
A Rare Thymic Tumor - Lipofibroadenoma - Always a Postoperative Surprise.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- Thymolipoma and lipofibroadenoma, two sides of the same coin?Mediastinum (Hong Kong, China) · 2026Article
- Thymic lipofibroadenoma: A case report.Radiology case reports · 2024Article
- Surgical resection of a giant thymolipoma causing respiratory failure: A case report.World journal of clinical cases · 2023Article
- Thymic lipofibroadenomas: Three case reports.World journal of clinical cases · 2023Article
- Lipofibroadenoma and other rare thymic tumors: a call for misfits.Mediastinum (Hong Kong, China) · 2023Article
- Asymptomatic lipofibroadenoma in a 17-year-old male: a case report and literature review of a rare entity.Mediastinum (Hong Kong, China) · 2023Article
- Pulmonary Crohn's Disease or Crohn's Disease with Lung Sarcoidosis? A Case Report and Literature Review.Healthcare (Basel, Switzerland) · 2022Review
- Thymofibrolipoma: a case report and review of the literature.Diagnostic pathology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 6 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimThymic lipofibroadenoma is a benign growth of unknown etiology extremely rarely described in the literature, morphologically resembling lipofibroadenoma of the breast. The diagnosis is usually a postoperative surprise and is made by the anatomopathologist. Surgical resection is curative. CASE REPORT: The presented case is the first reported in a woman, to date. The patient was successfully submitted to surgery and complete resection of the giant intrathoracic tumor was performed. The histopathological and immunohistochemical studies came to demonstrated the presence of a thymic lipofibroadenoma while the postoperative outcomes were favorable.
conclusionIn cases presenting large intrathoracic tumors complete resection is able to provide a significant improvement of the general condition of the patient, as well as a chance for cure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.